PTEN and lung carcinoma: In summary, our study is the first to demonstrate that phosphorylation sites in the PTEN C-terminus might be a promising therapeutic target to negatively regulate TGFβ-induced aberrant activities such as EMT, cell motility, and aggressive tumor growth in lung cancer cells.